SPRAVATO for treatment-resistant depression – the new hit depression treatment?
For many patients struggling with treatment-resistant depression, it can feel like there are no solutions for the challenges they face. Enter SPRAVATO, an FDA-approved depression treatment proven to be 2.5x more effective for patients who failed 2+ medications for depression.
Derived from the anesthetic ketamine, SPRAVATO works similarly to antidepressants by supporting the brain’s neurotransmitters and raising the levels of dopamine, norepinephrine, and serotonin. Unlike antidepressants, SPRAVATO increases the brain’s glutamate levels, in turn creating new connections in the brain that rapidly improve symptoms of depression.
Let’s take a deeper dive into how SPRAVATO works and its effect on patients with depression in this podcast from The Journal:
Leaders in Depression Care Innovation
At Mindful Health Solutions, we are proud to be one of the lead providers of interventional psychiatry treatments for depression in the United States. With clinics spanning California, Washington, and Texas, we reach a multitude of individuals struggling with treatment-resistant depression. In fact, 65% of patients with treatment-resistant depression respond positively to SPRAVATO, with full remission possible.
There is hope, and cutting-edge treatments have been proven to lead patients to a healthier mental well-being. Contact us today for a consultation at (888) 789-6013 or https://mindfulhealthsolutions.com/contact-us/.